🕵️ Milestone Pharmaceuticals Inc. ($MIST)
SEC insider & ownership activity, last 12 months · CIK 1408443 · every row links its SEC filing
Over the last 12 months insiders sold $1.2M with no open-market buying against it. Joseph Oliveto sold $556K (Dec–Apr). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $1.2M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Joseph Oliveto | 0 | – | 5 | $556K | Apr 16, 2026 |
| Bharucha David | 0 | – | 2 | $158K | Jan 26, 2026 |
| Hasija Amit | 0 | – | 2 | $158K | Jan 26, 2026 |
| Nelson Jeffrey Edward | 0 | – | 2 | $158K | Jan 26, 2026 |
| Muller Lorenz | 0 | – | 2 | $146K | Jan 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Roderick WONG, M.D. | 10.0% | 13G | Feb 14, 2025 | filing ↗ | |
| Propel BIO Management, LLC | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Leen Kawas | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Richard Kayne | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Propel BIO Partners LLC | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| RTW Investments, LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Roderick Wong | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Adage Capital Management, L.P. | 6.4% | 13G | May 13, 2026 | filing ↗ | |
| Robert Atchinson | 6.4% | 13G | May 13, 2026 | filing ↗ | |
| Phillip Gross | 6.4% | 13G | May 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Joseph Oliveto | $80K | Apr 16, 2026 | filing ↗ |
| Joseph Oliveto | $171K | Jan 8, 2026 | filing ↗ |
| Joseph Oliveto | $1K | Jan 7, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Jan 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 26, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 12, 2025 | filing ↗ |
| Other events (8.01) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |